AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34

Authors: Hoedemaeker, RF van der Kwast, TH Boer, R de Koning, HJ Roobol, M Vis, AN Schroder, FH
Citation: Rf. Hoedemaeker et al., Pathologic features of prostate cancer found at population-based screeningwith a four-year interval, J NAT CANC, 93(15), 2001, pp. 1153-1158

Authors: Bindels, EMJ Vermey, M De Both, NJ van der Kwast, TH
Citation: Emj. Bindels et al., Influence of the microenvironment on invasiveness of human bladder carcinoma cell lines, VIRCHOWS AR, 439(4), 2001, pp. 552-559

Authors: van der Flier, S van der Kwast, TH Claassen, CJC Timmermans, M Brinkman, A Henzen-Logmans, SC Foekens, JA Dorssers, LCJ
Citation: S. Van Der Flier et al., Immunohistochemical study of the BCAR1/p130Cas protein in non-malignant and malignant human breast tissue, INT J B MAR, 16(3), 2001, pp. 172-178

Authors: Altun, V Hakvoort, TE van Zuijlen, PPM van der Kwast, TH Prens, EP
Citation: V. Altun et al., Nerve outgrowth and neuropeptide expression during the remodeling of humanburn wound scars - A 7-month follow-up study of 22 patients, BURNS, 27(7), 2001, pp. 717-722

Authors: Vis, AN Hoedemaeker, RF Roobol, M van der Kwast, TH Schroder, FH
Citation: An. Vis et al., Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0-3.9 ng/ml), PROSTATE, 47(4), 2001, pp. 252-261

Authors: Vis, AN Hoedemaeker, RF van der Kwast, TH Schroder, FH
Citation: An. Vis et al., Defining the window of opportunity in screening for prostate cancer: Validation of a predictive tumor classification model, PROSTATE, 46(2), 2001, pp. 154-162

Authors: Jimenez, N Jongsma, J Calvo, A van der Kwast, TH Treston, AM Cuttitta, F Schroder, FH Montuenga, LM van Steenbrugge, GJ
Citation: N. Jimenez et al., Peptidylglycine alpha-amidating monooxygenase- and proadrenomedullin-derived peptide-associated neuroendocrine differentiation are induced by androgen deprivation in the neoplastic prostate, INT J CANC, 94(1), 2001, pp. 28-34

Authors: van Rhijn, BWG Lurkin, I Radvanyi, F Kirkels, WJ van der Kwast, TH Zwarthoff, EC
Citation: Bwg. Van Rhijn et al., The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate, CANCER RES, 61(4), 2001, pp. 1265-1268

Authors: Foekens, JA Peters, HA Grebenchtchikov, N Look, MP Meijer-van Gelder, ME Geurts-Moespot, A van der Kwast, TH Sweep, CGJ Klijn, JGM
Citation: Ja. Foekens et al., High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer, CANCER RES, 61(14), 2001, pp. 5407-5414

Authors: van Rhijn, BWG Lurkin, I Kirkels, WJ van der Kwast, TH Zwarthoff, EC
Citation: Bwg. Van Rhijn et al., Microsatellite analysis - DNA test in urine competes with cystoscopy in follow-up of superficial ladder carcinoma - A phase II trial, CANCER, 92(4), 2001, pp. 768-775

Authors: Vis, AN Hoedemaeker, RF Roobol, M Schroder, FH van der Kwast, TH
Citation: An. Vis et al., The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma - An evaluation from a randomized, population-basedstudy of screening for prostate cancer, CANCER, 92(3), 2001, pp. 524-534

Authors: Alers, JC Krijtenburg, PJ Vis, AN Hoedemaeker, RF Wildhagen, MF Hop, WCJ van der Kwast, TH Schroder, FH Tanke, HJ van Dekken, H
Citation: Jc. Alers et al., Molecular cytogenetic analysis of prostatic adenocarcinomas from screeningstudies - Early cancers may contain aggressive genetic features, AM J PATH, 158(2), 2001, pp. 399-406

Authors: Hakvoort, TE Altun, V van Zuijlen, PPM de Boer, WI van Schadewijk, WAAM van der Kwast, TH
Citation: Te. Hakvoort et al., Transforming growth factor (TGF)-beta(1), -beta(2), -beta(3), basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) expression in keratinocytes of burn scars, EUR CYTOKIN, 11(2), 2000, pp. 233-239

Authors: Vis, AN Kranse, R Nigg, AL van der Kwast, TH
Citation: An. Vis et al., Quantitative analysis of the decay of immunoreactivity in stored prostate needle biopsy sections, AM J CLIN P, 113(3), 2000, pp. 369-373

Authors: van Tilborg, AAG de Vries, A de Bont, M Groenfeld, LE van der Kwast, TH Zwarthoff, EC
Citation: Aag. Van Tilborg et al., Molecular evolution of multiple recurrent cancers of the bladder, HUM MOL GEN, 9(20), 2000, pp. 2973-2980

Authors: Jongsma, J Oomen, MHA Noordzij, MA Romijn, JC van der Kwast, TH Schroder, FH van Steenbrugge, GJ
Citation: J. Jongsma et al., Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines, PROSTATE, 42(1), 2000, pp. 34-44

Authors: Vis, AN Boerma, MO Ciatto, S Hoedemaeker, RF Schroder, FH van der Kwast, TH
Citation: An. Vis et al., Detection of prostate cancer: A comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy, UROLOGY, 56(4), 2000, pp. 617-621

Authors: Verkaik, NS van Steenbrugge, GJ van Weerden, WM Bussemakers, MJ van der Kwast, TH
Citation: Ns. Verkaik et al., Silencing of CD44 expression in prostate cancer by hypermethylation of theCD44 promoter region, LAB INV, 80(8), 2000, pp. 1291-1298

Authors: Vis, AN Noordzij, MA Fitoz, K Wildhagen, MF Schroder, FH van der Kwast, TH
Citation: An. Vis et al., Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer, J UROL, 164(6), 2000, pp. 2156-2161

Authors: Hoedemaeker, RF Rietbergen, JBW Kranse, R Schroder, FH van der Kwast, TH
Citation: Rf. Hoedemaeker et al., Histopathological prostate cancer characteristics at radical prostatectomyafter population based screening, J UROL, 164(2), 2000, pp. 411-415

Authors: Jongsma, J Oomen, MH Noordzij, MA Van Weerden, WM Martens, GJM van der Kwast, TH Schroder, FH van Steenbrugge, GJ
Citation: J. Jongsma et al., Androgen deprivation of the prohormone convertase-310 human prostate cancer model system induces neuroendocrine differentiation, CANCER RES, 60(3), 2000, pp. 741-748

Authors: van Schaik, RHN Wierikx, CDJ Timmerman, MA Oomen, MH van Weerden, WM van der Kwast, TH van Steenbrugge, GJ de Jong, FH
Citation: Rhn. Van Schaik et al., Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues, BR J CANC, 82(1), 2000, pp. 112-117

Authors: Alexander, FE Andriole, GL Aus, G Auvinen, A Beensterboer, P Blijenberg, BG Bonardi, R Buys, S Candas, B Ciatto, S Crawford, ED Demers, R de Koning, HJ Denis, L Dijk, MA Figueiredo, F Gellman, EP Gohagan, J Hakama, M Hugosson, J Kirkels, WI Kranse, R van der Kwast, TH Lilja, H Maattanen, L Mandel, J Miller, AB Monteiro, H Nelen, V Oberman, A Paez, A Prorok, PC Reding, D Rietbergen, JWBW Rose, DB Sanchez, AB Schroder, FH da Silva, EC Simpson, N Smith, PH Stadaert, B Stenman, UH Teppo, L Turkes, A Weissfeld, JL Yokochi, L
Citation: Fe. Alexander et al., Rationale for randomised trials of prostate cancer screening, EUR J CANC, 35(2), 1999, pp. 262-271

Authors: Hakvoort, TE Altun, V Ramrattan, RS van der Kwast, TH Benner, R van Zuijlen, PPM Vloemans, AFPM Prens, EP
Citation: Te. Hakvoort et al., Epidermal participation in post-burn hypertrophic scar development, VIRCHOWS AR, 434(3), 1999, pp. 221-226

Authors: van der Kwast, TH Labrie, F Tetu, B
Citation: Th. Van Der Kwast et al., Prostatic intraepithelial neoplasia and endocrine manipulation, EUR UROL, 35(5-6), 1999, pp. 508-510
Risultati: 1-25 | 26-34